Cavazos-Rehg, Patricia A.
Krauss, Melissa J.
Sowles, Shaina J.
Bierut, Laura J.
Funding for this research was provided by:
National Institute on Drug Abuse (R01DA032843)
National Institute on Drug Abuse (R01DA039455)
Article History
First Online: 4 June 2016
Compliance with Ethical Standards
:
: This work was supported by the National Institutes of Health [grant numbers R01DA032843 (PCR), R01DA039455 (PCR)].
: One of the authors, Dr. Bierut, is listed as an inventor on Issued U.S. Patent 8, 080, 371, “Markers for Addiction,” covering the use of certain SNPs in determining the diagnosis, prognosis, and treatment of addiction. All other authors declare that they have no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: The Washington University Human Research Protection Office granted this study a non-human determination. Therefore, consent was not needed for this study.